Logo

Precipio Second-Generation HemeScreen Assays

Aug 16, 2022

Precipio has launched the second generation of its HemeScreen panels. The new assays reduce time and labor by eliminating confirmation step, reducing the process to a single step, the company said.

The New Haven, Connecticut-based cancer diagnostics company said the second-generation panels reduces the bench work needed to complete an assay by about 25 percent and shortens the turn-around time by eliminating that positive confirmation step required in first-generation panels. The new version of the assays delivers positive and negative results within about three hours.

Breaking News
The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.